Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin

Heart

Volumn 92, Issue 1, 2006, Pages 113-114

  Roy, D ^a,b   Quiles, J ^a   Gaze, D C ^a   Collinson, P ^a   Kaski, J C ^a   Baxter, Gary F ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; REACTIVE OXYGEN METABOLITE;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION;

BIOLOGICAL MARKERS; COBALT; HUMANS; MYOCARDIAL ISCHEMIA; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN;

EID: 29644446462     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.049643     Document Type: Article

References (6)

1. Morrow DA, De Lemos JA, Sabatine MS, et al. The search for a biomarker of cardiac ischemia. Clin Chem 2003;49:537-9.
2. Sinha M, Gaze DC, Tippins JR, et al. Ischemia-modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5.
3. Bar-Or D, Winkler JV, Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin-1. Am Heart J 2001;141:985-91.
4. Sinha MK, Roy D, Gaze DC, et al. Role of "ischemia-modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
5. Marx G, Chevion M. Site-specific modification of albumin by free radicals: reaction with copper(II) and ascorbate. Biochem J 1986;236:397-400.
6. Chan B, Dodsworth N, Woodrow J, et al. Site-specific N-terminal autodegradation of human serum albumin. Eur J Biochem 1995;227:524-8.